Aspirin

Healio and Cardiology Today present the most-read cardiology articles for the month of March.

The American College of Cardiology announced its lineup of late-breaking clinical trials selected for presentation at its virtual 2021 Scientific Session.

The use of aspirin and selective serotonin reuptake inhibitors, either as monotherapy or in combination, was associated with reduced risk for colorectal cancer, according to study results.

A new study demonstrated a nonlinear inverse relationship between fruit and vegetable consumption and overall mortality. It was the top story in cardiology last week.

Many adults aged at least 75 years are taking aspirin for primary CVD prevention despite lack of evidence, whereas many are not taking statins for primary CVD prevention despite strong evidence, researchers reported.

Any aspirin use and aspirin use at least three times per week appeared associated with improvements in survival outcomes among older adults with bladder and breast cancers, according to study results published in JAMA Network Open.

The effects found with low-dose rivaroxaban plus aspirin are consistent regardless of patient BMI and weight, according to research published in the Journal of the American College of Cardiology.

Long-term, regular use of aspirin before diagnosis appeared associated with lower colorectal cancer-specific mortality, according to results of an observational study published in Journal of the National Cancer Institute.

Women with previous pregnancy losses who adhered to a low-dose aspirin regimen while trying to conceive had better outcomes than women who received placebo, results from a per protocol analysis of a randomized trial showed.

Use of low-dose aspirin yielded a low risk of venous thromboembolism and medication-associated complications after primary shoulder arthroplasty, according to results presented at the American Shoulder and Elbow Surgeons Annual Meeting.